EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma

Yan Han iD, Chuntuan Li, Shengquan Liu, Jingjing Gao, Yanjun He, Huifang Xiao, Qi Chen, Yan Zheng, Hongyuan Chen, Xiongpeng Zhu

Hematological Oncology · 2024

DOI: 10.1002/hon.3305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Yan Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Zinc Finger Protein GLI1, Hedgehog Proteins, Wnt Signaling Pathway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mantle cell lymphoma (MCL) is a rare and aggressive form of non‐Hodgkin lymphoma. Challenges in its treatment include relapse, drug resistance, and a short survival period. The Hedgehog/GLI1 (Hh/GLI1) and Wnt/β‐catenin pathways are crucial in cancer cell proliferation, survival, and drug resistance, making them significant targets for anticancer research. This study aimed to assess the effectiveness of combining inhibitors for both pathways against MCL and investigate the underlying molecular mechanisms. The co‐expression of key proteins from the Hh/GLI1 and Wnt/β‐catenin pathways was observed in MCL. Targeting the Hh/GLI1 pathway with the GLI1 inhibitor GANT61 and the Wnt/β‐catenin pathway with the CBP/β‐catenin transcription inhibitor ICG‐001, dual‐target therapy was demonstrated to synergistically suppressed the activity of MCL cells. This approach promoted MCL cell apoptosis, induced G0/G1 phase blockade, decreased the percentage of S‐phase cells, and enhanced the sensitivity of MCL cells to the drugs adriamycin and ibrutinib. Both GANT61 and ICG‐001 downregulated GLI1 and β‐catenin while upregulating GSK‐3β expression. The interaction between Hh/GLI1 and Wnt/β‐catenin pathways was mediated by GANT61‐dependent Hh/GLI1 inhibition. Moreover, GLI1 knockdown combined with ICG‐001 synergistically induced apoptosis and increased drug sensitivity of MCL cells to doxorubicin and ibrutinib. GANT61 attenuated the overexpression of β‐catenin and decreased the inhibition of GSK‐3β in MCL cells. Overall, the combined targeting of both the Hh/GLI1 and Wnt/β‐catenin pathways was more effective in suppressing proliferation, inducing G0/G1 cycle retardation, promoting apoptosis, and increasing drug sensitivity of MCL cells than mono treatments. These findings emphasize the potential of combinatorial therapy for treating MCL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Mantle-CellZinc Finger Protein GLI1Hedgehog ProteinsWnt Signaling PathwayHumansCell Line, TumorPyridinesApoptosisBridged Bicyclo Compounds, HeterocyclicCell Proliferationbeta CateninPyrimidinesPyrimidinones

Stichwörter der Autor:innen

Hedgehog/GLI1Wnt/β‐catenincombination targetingmantle cell lymphomasignaling pathway

Substanzen

Zinc Finger Protein GLI1Hedgehog ProteinsGLI1 protein, humanICG 001PyridinesGANT 61Bridged Bicyclo Compounds, Heterocyclicbeta CateninPyrimidinesPyrimidinones

Autor:innen und Institutionen

  • Department of Hematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
  • Fujian Medical University, Fuzhou, China.
  • Department of Blood Transfusion, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.

ORCID-Profile: Yan Han

Förderung

  • Natural Science Foundation of Fujian Province

Zitieren

APA

Han, Y., Li, C., Liu, S., Gao, J., He, Y., Xiao, H., Chen, Q., Zheng, Y., Chen, H., & Zhu, X. (2024). Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.3305

Vancouver

Han Y, Li C, Liu S, Gao J, He Y, Xiao H, et al. Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma. Hematological Oncology. 2024. doi:10.1002/hon.3305

BibTeX
@article{Han2024,
  author = {Han, Yan and Li, Chuntuan and Liu, Shengquan and Gao, Jingjing and He, Yanjun and Xiao, Huifang and Chen, Qi and Zheng, Yan and Chen, Hongyuan and Zhu, Xiongpeng},
  title = {Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3305}
}
Kostenlos starten →